# TRAVERE THERAPEUTICS INC NOTE 0.500% 5/1

TRAVERE THERAPEUTICS INC NOTE 0.500% 5/1 is a security (CUSIP 89422GAB3) tracked across SEC portfolio filings. 8 institutional managers reported $135.4M on Form 13F as of 2026-06-30; 1 registered fund positions totaling $191K via N-PORT as of 2026-05-29.

## Summary

- Issuer: TRAVERE THERAPEUTICS INC
- Class: NOTE 0.500% 5/1
- CUSIP: 89422GAB3
- Asset category: DBT
- 13F holders: 8
- 13F value: $135.4M
- 13F period: 2026-06-30
- N-PORT fund positions: 1
- N-PORT value: $191K
- N-PORT report: 2026-05-29

## Top institutional holders (Form 13F)

| Manager | Location | Value | Shares |
| --- | --- | --- | --- |
| Context Capital Management, LLC | LAJOLLA, CA | $59.5M | 50,500,000 |
| [Calamos Advisors LLC](https://search.stillhousedata.com/firm/105758) | NAPERVILLE, IL | $57.6M | 48,813,000 |
| M&G PLC | London, X0 | $16.4M | 14,000,000 |
| [RWC Asset Management LLP](https://search.stillhousedata.com/firm/168656) | LONDON, X0 | $1.5M | 1,281,000 |
| Bank of New York Mellon Corp | NEW YORK, NY | $294K | 250,000 |
| [Calamos Wealth Management LLC](https://search.stillhousedata.com/firm/143490) | NAPERVILLE, IL | $121K | 103,000 |
| CHOREO, LLC | ROCKFORD, IL | $15K | 13,000 |
| FIFTH THIRD BANCORP | CINCINNATI, OH | $11K | 9,000 |

## Top fund holders (N-PORT)

| Fund | Registrant | Value | % of fund |
| --- | --- | --- | --- |
| [Franklin Alternative Strategies Fund](https://search.stillhousedata.com/fund/S000042023) | Franklin Alternative Strategies Funds | $191K | 3.25% |

## More

- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/security/89422GAB3.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.